Abstract:Background: Although the incidence of positive resection margins in breast-conserving surgery has decreased, both incomplete resection and unnecessary large resections still occur. This is especially the case in the surgical treatment of ductal carcinoma in situ (DCIS). Diffuse reflectance spectroscopy (DRS), an optical technology based on light tissue interactions, can potentially characterize tissue during surgery thereby guiding the surgeon intraoperatively. DRS has shown to be able to discriminate pure healthy breast tissue from pure invasive carcinoma (IC) but limited research has been done on (1) the actual optical characteristics of DCIS and (2) the ability of DRS to characterize measurements that are a mixture of tissue types. Methods: In this study, DRS spectra were acquired from 107 breast specimens from 107 patients with proven IC and/or DCIS (1488 measurement locations). With a generalized estimating equation model, the differences between the DRS spectra of locations with DCIS and IC and only healthy tissue were compared to see if there were significant differences between these spectra. Subsequently, different classification models were developed to be able to predict if the DRS spectrum of a measurement location represented a measurement location with "healthy" or "malignant" tissue. In the development and testing of the models, different definitions for "healthy" and "malignant" were used. This allowed varying the level of homogeneity in the train and test data. Results: It was found that the optical characteristics of IC and DCIS were similar. Regarding the classification of tissue with a mixture of tissue types, it was found that using mixed measurement locations in the development of the classification models did not tremendously improve the accuracy of the classification of other measurement locations with a mixture of tissue types. The evaluated classification models were able to classify measurement locations with > 5% malignant cells with a Matthews correlation coefficient of 0.41 or 0.40. Some models showed better sensitivity whereas others had better specificity. Conclusion: The results suggest that DRS has the potential to detect malignant tissue, including DCIS, in healthy breast tissue and could thus be helpful for surgical guidance.

Explore The Differences And Relationships Between Normal And Adh, Dcis And Idc Tissues In Breast Based On Raman Spectroscopy

Differentiating Laryngeal Carcinomas from Precursor Lesions by Diffusion-Weighted Magnetic Resonance Imaging at 3.0 T: a Preliminary Study.

Morphologic changes of breast carcinoma after neoadjuvant therapy and its differential diagnosis

Raman Microspectroscopic Investigation and Classification of Breast Cancer Pathological Characteristics

Molecular Fingerprint of Precancerous Lesions in Breast Atypical Hyperplasia.

Advances in the clinical application of Raman spectroscopy in breast cancer

Diagnosing molecular subtypes of breast cancer by means of Raman spectroscopy

Assessing pathological features of breast cancer via the multimodal information of multiphoton and Raman imaging

High-content stimulated Raman histology of human breast cancer

Studies on Human Breast Cancer Tissues with Raman Microspectroscopy

Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance

Correlation of Automated Breast Volume Scanner Imaging and the Difference of Molecular Subtypes Between Core Needle Biopsy and Surgical Specimens

Label-free ex vivo pathological studying on breast cancer tissue by using nonlinear multiphoton and micro-Raman spectral imaging

Computerized Image Analysis to Differentiate Benign and Malignant Breast Tumors on Magnetic Resonance Diffusion Weighted Image: A Preliminary Study

Comparative FTIR Spectroscopic Analysis of Human Breast Benign and Malignant Tissues

Spectrum of atypical ductal hyperplasia (ADH) and ductal carcinoma in-situ (DCIS): Diagnostic challenges

Polarized Micro-Raman Spectroscopy and 2D Convolutional Neural Network Applied to Structural Analysis and Discrimination of Breast Cancer

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

Visible and near-infrared spectroscopy for distinguishing malignant tumor tissue from benign tumor and normal breast tissues in vitro

Whole-lesion Histogram Analysis of Apparent Diffusion Coefficient for Distinguishing Cervical Cancers with Different Differentiation

Serum Raman spectroscopy combined with multiple classification models for rapid diagnosis of breast cancer